ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GWP GW Pharm.

735.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
GW Pharm. LSE:GWP London Ordinary Share GB0030544687 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 735.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Director/PDMR Shareholding (9346A)

09/02/2011 10:25am

UK Regulatory


Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Gw Pharmaceuticals Charts.

TIDMGWP

RNS Number : 9346A

GW Pharmaceuticals PLC

09 February 2011

GW Pharmaceuticals PLC

GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")

NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

Porton Down, UK, 9 February 2011: GW Pharmaceuticals (AIM: GWP) hereby provides notification that the Company has today been notified of the following share transactions entered into on 4 February 2011 by Mr Thomas Lynch, non-executive Director and Dr Geoffrey Guy, a Director and Executive Chairman of the Company.

Mr Thomas Lynch purchased 188,679 ordinary shares of 0.1p each from Dr Geoffrey Guy. This transaction between Directors, which equates to 0.14% of the issued ordinary share capital of the company, took place at the market price of 106 pence per share.

Following this notification:

Mr Lynch's holding in the shares of GW Pharmaceuticals PLC has increased to 236,344 ordinary shares of 0.1 pence each, amounting to 0.18% of shares in issue.

Dr Guy holds a beneficial interest in 18,068,104GW Pharmaceuticals plc ordinary shares of 0.1 pence each, representing 13.73% of the Company's current issued share capital.

The total number of shares outstanding in the Company is 131,549,592 ordinary shares of 0.1 pence each.

- Ends -

Enquiries:

GW Pharmaceuticals PLC Tel: +44 (0)1980 557 000

Adam George, Company Secretary

Peel Hunt LLP (Nominated Advisor) Tel: +44 (0)207 418 8900

James Steel/Vijay Barathan

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLLFFIFSIAIIL

1 Year Gw Pharmaceuticals Chart

1 Year Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock